|
|
|
Insider
Information: |
Maraganore John |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
263,534 |
|
Indirect Shares
|
6,153,633 |
|
|
Direct
Value |
$35,430,768 |
|
|
Indirect Value
|
$14,183,372 |
|
|
Total
Shares |
6,417,167 |
|
|
Total
Value |
$49,614,140 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Executive Office... |
2021-12-22 |
227,663 |
2021-12-22 |
3,133 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
30,028 |
|
0 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
Director |
2017-09-14 |
5,843 |
2014-07-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
154 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2013-07-10 |
4 |
OE |
$0.95 |
$57,000 |
D/D |
60,000 |
78,617 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2013-08-14 |
4 |
OE |
$0.95 |
$57,000 |
D/D |
60,000 |
78,617 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2013-09-11 |
4 |
OE |
$0.95 |
$56,000 |
D/D |
58,947 |
77,564 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2013-10-10 |
4 |
OE |
$6.78 |
$85,869 |
D/D |
12,665 |
31,282 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2014-02-03 |
4 |
OE |
$6.78 |
$314,124 |
D/D |
46,331 |
77,613 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2014-04-14 |
4 |
OE |
$9.14 |
$524,962 |
D/D |
28,707 |
106,320 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2014-05-14 |
4 |
OE |
$6.78 |
$385,335 |
D/D |
56,834 |
163,154 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2014-05-15 |
4 |
OE |
$6.78 |
$400,973 |
D/D |
56,834 |
163,154 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2014-06-25 |
4 |
OE |
$7.47 |
$424,550 |
D/D |
56,834 |
163,154 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2014-06-26 |
4 |
OE |
$7.47 |
$424,550 |
D/D |
56,834 |
163,154 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2014-09-17 |
4 |
OE |
$7.47 |
$424,550 |
D/D |
56,834 |
161,454 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2014-09-18 |
4 |
OE |
$7.47 |
$424,550 |
D/D |
56,834 |
161,454 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2014-12-15 |
4 |
OE |
$9.14 |
$74,994 |
D/D |
8,205 |
112,825 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2015-11-20 |
4 |
OE |
$7.10 |
$845,017 |
D/D |
69,254 |
192,079 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2015-12-02 |
4 |
OE |
$13.12 |
$770,000 |
D/D |
58,689 |
192,078 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-01-19 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-01-20 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-04-19 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-04-20 |
4 |
OE |
$22.75 |
$342,956 |
D/D |
15,075 |
148,464 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2016-07-19 |
4 |
OE |
$22.75 |
$342,979 |
D/D |
15,076 |
148,465 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2016-07-20 |
4 |
OE |
$22.75 |
$342,956 |
D/D |
15,075 |
148,464 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-10-12 |
4 |
OE |
$7.10 |
$99,994 |
D/D |
7,540 |
140,929 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2016-12-12 |
4 |
OE |
$22.75 |
$685,935 |
D/D |
30,151 |
171,080 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2017-01-05 |
4 |
OE |
$18.66 |
$25,004 |
D/D |
1,340 |
149,710 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-03-03 |
4 |
OE |
$0.95 |
$71,923 |
D/D |
13,839 |
18,682 |
0 |
- |
|
154 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|